| Inhibitors of androgen receptor activation function-2 (AF2) site identified through virtual screening P Axerio-Cilies, NA Lack, MRS Nayana, KH Chan, A Yeung, E Leblanc, ... Journal of medicinal chemistry 54 (18), 6197-6205, 2011 | 107 | 2011 |
| Targeting the Binding Function 3 (BF3) Site of the Androgen Receptor Through Virtual Screening. 2. Development of 2-((2-phenoxyethyl) thio)-1H-benzimidazole … RSN Munuganti, E Leblanc, P Axerio-Cilies, C Labriere, K Frewin, ... Journal of medicinal chemistry 56 (3), 1136-1148, 2013 | 96 | 2013 |
| Identification of a potent antiandrogen that targets the BF3 site of the androgen receptor and inhibits enzalutamide-resistant prostate cancer RSN Munuganti, MDH Hassona, E Leblanc, K Frewin, K Singh, D Ma, ... Chemistry & biology 21 (11), 1476-1485, 2014 | 81 | 2014 |
| Discovery of 1H-Indole-2-carboxamides as Novel Inhibitors of the Androgen Receptor Binding Function 3 (BF3) F Ban, E Leblanc, H Li, RSN Munuganti, K Frewin, PS Rennie, ... Journal of medicinal chemistry 57 (15), 6867-6872, 2014 | 63 | 2014 |
| CoMFA and docking studies on triazolopyridine oxazole derivatives as p38 MAP kinase inhibitors MRS Nayana, YN Sekhar, NS Kumari, SK Mahmood, M Ravikumar European Journal of Medicinal Chemistry 43 (6), 1261-1269, 2008 | 52 | 2008 |
| Targeting prostate cancer subtype 1 by forkhead box M1 pathway inhibition K Ketola, RSN Munuganti, A Davies, KM Nip, JL Bishop, A Zoubeidi Clinical Cancer Research 23 (22), 6923-6933, 2017 | 35 | 2017 |
| Targeting binding function-3 of the androgen receptor blocks its co-chaperone interactions, nuclear translocation, and activation N Lallous, E Leblanc, RSN Munuganti, MDH Hassona, NA Nakouzi, ... Molecular cancer therapeutics 15 (12), 2936-2945, 2016 | 30 | 2016 |
| In silico discovery and validation of potent small-molecule inhibitors targeting the activation function 2 site of human oestrogen receptor α K Singh, RSN Munuganti, E Leblanc, YL Lin, E Leung, N Lallous, M Butler, ... Breast Cancer Research 17, 1-17, 2015 | 30 | 2015 |
| Structural analysis of carboline derivatives as inhibitors of MAPKAP K2 using 3D QSAR and docking studies RS Nayana, SK Bommisetty, K Singh, SK Bairy, S Nunna, A Pramod, ... Journal of chemical information and modeling 49 (1), 53-67, 2009 | 27 | 2009 |
| 3D-QSAR and molecular docking studies of 1, 3, 5-triazene-2, 4-diamine derivatives against r-RNA: novel bacterial translation inhibitors YN Sekhar, MRS Nayana, N Sivakumari, M Ravikumar, SK Mahmood Journal of Molecular Graphics and Modelling 26 (8), 1338-1352, 2008 | 20 | 2008 |
| Characterization of a small molecule inhibitor of disulfide reductases that induces oxidative stress and lethality in lung cancer cells FD Johnson, J Ferrarone, A Liu, C Brandstädter, R Munuganti, ... Cell reports 38 (6), 2022 | 13 | 2022 |
| Targeting semaphorin 3C in prostate cancer with small molecules CCW Lee, RSN Munuganti, JW Peacock, K Dalal, IZF Jiao, A Shepherd, ... Journal of the Endocrine Society 2 (12), 1381-1394, 2018 | 13 | 2018 |
| Benzothiophenone derivatives targeting mutant forms of estrogen receptor-α in hormone-resistant breast cancers K Singh, RSN Munuganti, N Lallous, K Dalal, JS Yoon, A Sharma, ... International Journal of Molecular Sciences 19 (2), 579, 2018 | 11 | 2018 |
| Development of a benzothiazole scaffold-based androgen receptor n-terminal inhibitor for treating androgen-responsive prostate cancer NC Kuznik, V Solozobova, N Jung, S Gräßle, Q Lei, EM Lewandowski, ... ACS Chemical Biology 16 (11), 2103-2108, 2021 | 9 | 2021 |
| Insight into the structural requirements of proton pump inhibitors based on CoMFA and CoMSIA studies MRS Nayana, YN Sekhar, H Nandyala, R Muttineni, SK Bairy, K Singh, ... Journal of Molecular Graphics and Modelling 27 (3), 233-243, 2008 | 8 | 2008 |
| Drug-discovery pipeline for novel inhibitors of the androgen receptor K Dalal, R Munuganti, H Morin, N Lallous, PS Rennie, A Cherkasov The Nuclear Receptor Superfamily: Methods and Protocols, 31-54, 2016 | 5 | 2016 |
| Comparative molecular field analysis of quinoline derivatives as selective and noncompetitive mGluR1 antagonists Y Nataraja Sekhar, M Ravi Shashi Nayana, M Ravikumar, S Mahmood Chemical biology & drug design 70 (6), 511-519, 2007 | 5 | 2007 |
| 3D-QSAR studies of triazafluorenone inhibitors of metabotropic glutamate receptor subtype 1 YN Sekhar, M Ravikumar, MRS Nayana, SC Mallena, MK Kumar European journal of medicinal chemistry 43 (5), 1025-1034, 2008 | 4 | 2008 |
| Identification of an Imidazopyridine-based Compound as an Oral Selective Estrogen Receptor Degrader for Breast Cancer Therapy CACB Pan M, Solozobova V, Kuznik NC, Jung N, Gräßle S, Gourain V, Heneka YM ... Cancer Res Commun 3 (7), 1378-1396, 2023 | 3 | 2023 |
| First-in-field small molecule inhibitors targeting BRN2 as a therapeutic strategy for small cell prostate cancer. DL Thaper, R Munuganti, S Nouruzi, S Kumar, S Kim, S Vahid, O Sivak, ... Journal of Clinical Oncology 37 (7_suppl), 260-260, 2019 | 3 | 2019 |
